License and Distribution Agreements (Details Narrative) - USD ($) $ in Thousands						3 Months Ended		6 Months Ended	12 Months Ended
	Dec. 11, 2023	Aug. 25, 2023	Jul. 31, 2023	Apr. 10, 2023	Mar. 17, 2023	Dec. 31, 2024	Mar. 31, 2024	Jun. 30, 2025	Dec. 31, 2023	Sep. 30, 2025
Deferred revenue								$ 1,208
Issuance of common stock							$ 6,000
Purchase and sale of shares			857,142
Common Stock [Member]
Issuance of common stock
Purchase and sale of shares							2,141,098
Common Class A [Member]
Purchase and sale of shares				923,076
Regeneron Research Collaboration Services Agreement [Member]
Service agreement term		5 years
License agreement notice period		30 days
Regeneron Services Agreement [Member]
Received payments								1,325
Revenues						$ 688
Deferred revenue								$ 637
Regeneron Services Agreement [Member] | Subsequent Event [Member]
Deferred revenue										$ 637
Pulthera LLC Binding Term Sheet [Member]
Payment of option fee in cash									$ 3,000
Pulthera LLC Binding Term Sheet [Member] | Research and Development Expense [Member]
Option fee expense					$ 3,000
Pulthera LLC Binding Term Sheet [Member] | Common Stock [Member]
Purchase and sale of shares					169,492
Pulthera LLC Binding Term Sheet [Member] | Common Class A [Member]
Issuance of common stock									$ 1,000
License Agreement with Biocellgraft Inc [Member]
Commercial license	4 years
License fee expense	$ 5,000
License fees payment period	2 years
License fee payment	$ 300
Additional license fee	$ 300